News

High-throughput screening is essential in drug discovery, but traditional screening methods often struggle with complexity, throughput limitations and resolution challenges, making it difficult to ...
SOUTH SAN FRANCISCO, Calif., May 25, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive ...